Pfizer is leaving no stone unturned in its efforts to prevent Novo Nordisk from stealing off with Metsera, the weight-loss therapy developer it is hoping to acquire in a deal worth up to $7.3 billion.

Sen. Telo Taitague faces another ethics complaint from former Sen. Tom Fisher, who is now accusing her of pushing for payments to the Office of the Attorney General in exchange for free legal ...